NEU neuren pharmaceuticals limited

Ann: Patent to 2034 granted in Europe for Neuren's NNZ-2591, page-8

  1. 388 Posts.
    lightbulb Created with Sketch. 243
    Ha - So true!

    Treagus and Co have done a great job fuelling the rocket with the Acadia deal, IP protections and market exclusivity. Just need a ROW deal to have it full to the brim. Still need the ignition source though and that will be the Trofinetide P3 result. Not only does this unlock Trofinetide, but I think it gives the market full confidence that NNZ-2591 will deliver also, and wooshka.

    I think the SP will tick up over time in anticipation of the P3 result but only modestly as it is a binary event. The result is going to be a rocket either up or down. A while to wait yet but hold on to your hats.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.